Reuters: Health
Apellis Pharmaceuticals Inc said on Tuesday its experimental drug for a blood disorder showed greater improvement in patients' hemoglobin levels than Alexion Pharmaceuticals Inc's Soliris, in a late-stage study.
| submitted by /u/mvea [link] [comments] |
| submitted by /u/mvea [link] [comments] |
| submitted by /u/mvea [link] [comments] |
Subscribe UsPopular Posts
|